id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
2684230,830b5b4e-ae0d-44f8-a7cb-bdf2f6fc8d95,Q3,"MEHLMAN CONSULTING, INC.",284950,VIZIENT INC,2021,third_quarter,PHA,Issues related to Unapproved Drug Initiative.,"Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office",60000,,0,0,2021-10-18T10:50:09.973000-04:00